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A B S T R A C T
Cattle are commonly subclinically infected following natural or experimental infection
with bluetongue virus (BTV). The introduction of BTV serotype 8 (BTV-8) in Europe has
been characterized by the manifestation of clinical signs in infected cattle. In order to
study the pathogenesis of BTV-8 in this host, an animal model able to reproduce the
clinical manifestations of the disease is required. In this work, two calves were
subcutaneously and intravenously injected with a low passage cell-adapted strain of BTV-
8. Both calves showed typical bluetongue clinical signs, including pyrexia, ocular
discharge, conjunctivitis, oral mucosal congestion, development of ulcers and necrotic
lesions on the lips and tongue, submandibular oedema, coronitis and oedema of the
coronet and pastern region. A score was assigned depending on the severity of the lesions
and a total clinical score was calculated for each animal daily and at the end of the
experiment. Both calves became viraemic 24 h post-infection and seroconversion
occurred between 7 and 11 days P.I.
In this study we present the development of a protocol of infection in calves able to
reproduce the severity of the lesions observed with BTV-8 in ﬁeld conditions.
 2008 Elsevier B.V. All rights reserved.1. Introduction
Bluetongue virus (BTV) is an arthropod-borne pathogen
infectingmost species of domestic andwild ruminants and
causing high economical loss in the international move-
ment and animal trade (MacLachlan and Osburn, 2006).
BTV belongs to the genus Orbivirus within the family
Reoviridae, and at present 24 serotypes have been
identiﬁed (Mellor and Wittmann, 2002). Clinical signs
commonly occur in sheep, while goats and cattle remain* Corresponding author. Tel.: +32 4 366 45 79; fax: +32 4 366 42 61.
E-mail address: claude.saegerman@ulg.ac.be (C. Saegerman).
0378-1135/$ – see front matter  2008 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetmic.2008.11.012mostly subclinically infected (Osburn, 1994). Although the
pathogenesis of bluetongue is similar in sheep and cattle
(MacLachlan et al., 1990), it is uncertain as to why BTV
infection causes extensive microvascular injury in sheep,
but less in cattle. Recently the role of species-speciﬁc
endothelial cell-derived inﬂammatory and vasoactive
mediators has been shown (DeMaula et al., 2002).
Since the summer 2006, BTV serotype 8 (BTV-8)
appeared in northern and central Europe with striking
epidemiological aspects, like the higher proportion of
cattle showing clinical signs and the involvement of new
Culicoides vectors during viral transmission (Saegerman
et al., 2008a). During the 2006–2007 outbreaks of BTV-8 in
northern and central Europe (Toussaint et al., 2007b),
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ulcerative and necrotic lesions on the muzzle and in the
oral cavity, conjunctivitis, lacrimation, periocular derma-
titis, photosensitivity-like lesions, drop inmilk production,
loss of body condition, ulcerative and necrotic lesions on
the teats, udder and vulva, oedema of the distal limbs
(Thiry et al., 2006; Guyot et al., 2007; Elbers et al., 2008). In
Europe BTV-8 appeared to cause transplacental infection,
which was normally associated until now to live BTV
strains adapted in cell culture (MacLachlan et al., 2000;
Vercauteren et al., 2008; Wouda et al., 2008).
The understanding of the viral pathogenesis in cattle
during BTV-8 infection is still rather poor. There is a real
need of a reliable and reproducible experimental model to
study the viral–host interactions, including the develop-
ment of clinical signs associated to the infection. Many
experimental inoculation studies have been conducted to
characterize BTV pathogenesis in cattle, including a variety
of serotypes, animals of different ages and variousmethods
of inoculation. At present, only one study has been
published with BTV-8 experimental infected sheep and
cattle, where the latter did not show obvious clinical
manifestations of the disease, although the necropsy
revealed a generalized lymphadenopathy and, only in
one cattle, petechial haemorrhages on several organs
(Darpel et al., 2007).
The aim of our study was to reproduce, in experimen-
tally infected calves, the clinical signs of the disease
observed in naturally infected cattle with BTV-8. The
results obtained infecting two calves with BTV-8 are
presented, with particular emphasis to the characteriza-
tion and quantiﬁcation of the different clinical signs
observed during the experiment.
2. Materials and methods
2.1. Animals
Two 5 months old female Holstein calves have been
used in this study (calf 3179 and 3181). The animals were
bought from a French farm located in a BTV-free area and
being regularly monitored for BTV. Before the beginning of
the experiment, the calves and their dams were tested to
conﬁrm their seronegative and non-viraemic status for
BTV. Furthermore, they have been also tested for bovine
viral diarrhea virus (BVDV) (IDEXX HerdChek, Bovine Viral
Diarrhea Virus Ab; LSI, Kit TaqVet BVD) and infectious
bovine rhinotracheitis (IBR) with negative results. A
veterinarian was attesting the healthy conditions of the
selected calves after a detailed clinical examination.
2.2. Virus
Bluetongue virus serotype 8 (BTV-8) strain BEL2006/01
P2, isolated during the 2006 epidemic season in Belgium,
was used (Toussaint et al., 2007b). First the virus was
isolated from the EDTA–blood on embryonated chicken
eggs, and subsequently propagated on BHK-21 cell culture.
The second passage of the virus on BHK-21 cells had a titer
of 105.3 TCID50/ml and it was used as inoculum in our
experimental protocol.2.3. Experimental design
The experimental infection was performed during the
winter season, when the vector activity was reduced. The
calves were conﬁned in an insect-secure zone at the
Experimental Infectiology Platform (PFIE) of the INRA
centre of Tours (Nouzilly, France) and insects light traps
were installed at the entrance of the experimental area.
During the experiments, animals were treated following
the International Guiding Principles for Biomedical
Research Involving Animals as issued by the Council for
the International Organizations of Medical Sciences. Both
calves have been infected using BTV-8 strain BEL2006/01
P2. The infection has been performed in the neck using
2 ml of viral inoculum. The dose was administered 1 ml
subcutaneously (SC) and 1 ml intravenously (IV). After 14
days post-infection, animals were euthanized following an
IV injection of pentobarbital. Spleen, prescapular and
medistinic lymph nodes, tongue were collected from both
animals and stored at 80 8C for viral RNA detection.
2.4. Clinical examination
The animals were monitored daily by a veterinarian for
the duration of the experiment (15 days). The body
temperature and the development of clinical signs were
examined daily at the same moment of the day (in the
morning) (Jackson and Cockcroft, 2002), and a digital
camera was used to record the evolution of the lesions. A
standardizedclinical form forBTV infectionwasusedduring
the animal examination, in order to analyse systematically
the most affected organs and systems (Saegerman et al.,
2008b). In the daily clinical examination, we proceeded in
the methodological differentiation of general and speciﬁc
clinical signs. A major attention was orientated to the skin
and the visible mucous membranes, to the locomotor,
digestive, respiratory and nervous systems. In addition, for
clinical data, a score was attributed for each observed
clinical sign in order to quantify the severity of the lesion,
and the score of an individual calf was deﬁned as the sum of
all clinical signspresent. A total clinical scorewas calculated
for each animal daily, at the end of the experiment and also
for each group of clinical signs.
2.5. Laboratory analysis
2.5.1. Serological analysis
For serological analysis, whole bloodwas collected daily.
It was centrifuged at 3000 rpm for 10min and the serum
was stored subsequently at 20 8C. The ID Screen1 Blue-
tongue Competition ELISA kit (ID VET, Montpellier, France)
was used to detect the appearance of antibodies directed
against BTV. The cELISA was performed following manu-
facturer’s instructions. Besides the kit controls, a twofold
dilution series of an anti-BTV antibody positive reference
serum was included and the results were expressed as %
negativity (PN) as describedbyVandenbussche et al. (2008).
2.5.2. BTV detection in biological samples
EDTA–blood samples were collected daily and stored at
+4 8C. These samples were used to detect the levels of
Fig. 1. The variation of the body temperature of calf 3179 and 3181 during
the experimental infection with BTV-8 is shown in (A). The two black
horizontal lines delimit the physiological body temperature range in
calves (between 38.5 8C and 39.5 8C). (B) and (C) Illustration of the
antibody response and the dynamic of viraemia in calf 3179 and 3181,
respectively. The results of the serological analysis are expressed as % of
negativity and were calculated referring to the negative control. BTV
detection in EDTA–bloodwas performed by RT-qPCR and the results were
expressed in Ct values.
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Vandenbussche et al. (2008). In order to amplify BTV
genome, a RT-qPCR amplifying a region of BTV segment 5
(RT-qPCR_S5) was used (Toussaint et al., 2007a). Bovine
beta-actin was contemporarily ampliﬁed as internal
control (Toussaint et al., 2007a). Cycle threshold values
(Ct) for each sample were used to compare the daily blood
viral load.
BTV detection by RT-qPCR was also performed from
spleen, tongue, prescapolar and mediastinic lymph nodes
collected during necropsy and stored at 80 8C. Starting
from 100 mg of tissue, the RNAwas extracted using Trizol–
LS reagent (Gibco, Invitrogen). BTV and beta-actin RT-qPCR
were performed as described above.
2.6. Statistical analysis
The trends of clinical pattern in time and by group of
clinical signs were compared by using Spearman’s rank
correlation, called rs in the text (Dagnelie, 1998). A P value
<0.05 was considered as signiﬁcant.
3. Results and discussion
In this study we describe for the ﬁrst time the
occurrence of clinical signs in calves experimentally
infected with BTV-8. In the Bluetongue chapter of the
OIE Terrestrial Manual 2008, the use of wild type virus
with no ECE or cell culture passages is recommended
during the challenge of vaccinated animals in order to test
the efﬁcacy of the vaccine. The two calves included in the
study received a subcutaneous and an intravenous
injection of a BTV-8 strain with only two passages on
BHK-21 cell culture and with a high viral titer. The
intravenous injection of a virulent BTV strain is probably at
the origin of the successful reproduction of the severe
clinical signs that have been observed in the ﬁeld. Recently
severe bluetongue disease has been experimentally
induced in sheep using BTV-4 with the intravenous
injection of infectious blood (MacLachlan et al., 2008).
The possibility to reproduce the clinical manifestations
associated to BTV infection seems to be highly increased by
the use of a virulent strain inoculated intravenously. The
accuracy and reproducibility of the described experimen-
tal protocol will be evaluated using a larger number of
infected animals and taking into account the kind of
inoculum.
The clinical consequences observed in the two calves
were not dissimilar to the signs induced spontaneously by
BTV-8. The day after the infection the calves had pyrexia, a
sign which has been already observed in previous
experimental infection with BTV (Odeo´n et al., 1997;
Darpel et al., 2007). Probably related to the high levels of
viraemia of the following days, we measured a slight
increase in body temperature between 7 and 10 days P.I.
The daily body temperature, expressed in 8C and recorded
in the two calves during the experiment, is shown in
Fig. 1A. Since the ﬁrst day P.I., a bilateral aqueous ocular
discharge developed in calf 3179. In the following days, the
ocular discharge progressively became abundant, with a
mucus-purulent feature (Fig. 2A), associated to a bilateralconjunctivitis since 3 days P.I. (Fig. 2B). An enhanced
bilateral mucous ocular discharge was observed starting
from 12 days P.I. In calf 3181 the appearance of the ocular
discharge started since 4 days P.I. and it was complicated
by conjunctivitis at 10 days P.I. After 4 days P.I. and for the
Fig. 2. (A) The severity of the ocular discharge observed in calf 3179 after 4 days PI. After 3 days P.I. a remarkable conjunctivitis was observed in calf 3179 (B).
(C) Illustration of the nasal discharge observed in calf 3181. A diffused oral congestion was observed already 2 days P.I. in calf 3179 while the ﬁrst multiple
oral erosions appeared in the inner part of the above lip after 4 days P.I. ((D) and (E), respectively). (F) Submandibular oedema observed 6 days post-infection
in calf 3179.
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increased nasal discharge, although it conserved a
physiological watery feature (Fig. 2C). No sign of dyspnea
was observed in both calves. In calf 3179 a diffuse
congestion of the oral mucosa was observed already 2
days P.I., and multiple erosions appeared in the inner part
of the upper lip 4 days P.I. (Fig. 2D and E). The lesions were
associated with a congestion of the gum and the oral
mucosa of the inner lips. These erosions healed within
some days with the development of a scab 9 days P.I. Four
new smaller ulcers appeared 10–11 days P.I. These ulcers
were round and localized at the junction of the oralmucosa
and the skin at the right and left side of the lower and
upper lip. A generalized congestion of the gums and of the
oral mucosa was observed 5 days P.I. in calf 3181. The ﬁrst
oral ulcers in this animal appeared 11 days P.I. and theirlocalization and aspect were very similar to the lesions
described in calf 3179 at the same time of the infection.
Viral replication in the mouth was underlined by BTV RNA
detection in the tongue of both calves (data not shown).
This ﬁnding and the continuous generation of new lesions
in the oral cavity underlined the active in situ replication of
the virus. The importance of the oral cavity as a privileged
localization during viral pathogenesis was furthermore
underlined by the high scores attributed to the oral lesions
developed by both calves (Table 1). The frequent appear-
ance of oral clinical signs during spontaneous bluetongue
disease in cattle was already reported (Saegerman et al.,
2007; Elbers et al., 2008).
Starting from6 days P.I., a characteristic submandibular
oedema appeared in both animals (Fig. 2F). No other
oedemas were detected in the different regions of the head
Table 1
Clinical scores applied to BTV-8 induced lesions observed in calf 3179 and 3181.
Days post-infection Total score
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Body temperaturea
3179 0 2 0 0 0 0 0 0 0 1 1 0 0 0 0 4
3181 0 1 0 0 1 0 0 1 2 1 0 0 0 0 0 6
Ocular signsb
3179 0 1 1 2 2 2 1 1 1 0 0 0 1 2 1 15
3181 0 0 0 0 1 1 1 1 1 1 2 2 0 0 0 10
Oral lesionsc
3179 0 0 0 0 3 3 3 3 3 1 3 3 3 3 3 31
3181 0 0 0 0 0 1 1 1 1 1 1 3 3 3 3 18
Lesions to the locomotor systemd
3179 0 0 0 0 0 1 1 1 2 2 2 2 2 2 2 17
3181 0 0 0 0 0 0 0 1 1 1 2 2 2 2 2 13
Oedemae
3179 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 9
3181 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 9
Total clinical scoref
3179 0 3 1 2 5 6 6 6 7 5 7 6 7 8 7 76
3181 0 1 0 0 2 2 3 5 6 5 6 8 6 6 6 56
a Body temperature score: 0 (body temperature  39.5 8C), 1 (body temperature  39.6 8C  39.9 8C), 2 (body temperature  40 8C < 41 8C), and 3 (body
temperature > 41 8C).
b Ocular lesions score: 0 (absence of ocular clinical signs), 1 (ocular discharge), 2 (conjunctivitis was contemporarily observed), and 3 (with complicated
ocular dermatitis).
c Oral lesions score: 0 (absence of clinical signs), 1 (mucosal congestion), 2 (presence of one oral erosion or one ulcer), and 3 (multiple erosions or ulcers). In
the presence of a scab as a consequence of the healing process, a score of 1 was attributed.
d Locomotor system score: 0 (absence of clinical signs), 1 (congestion of the coronary band), 2 (congestion and oedema), and 3 (lameness).
e Oedema score: 0 (absence of oedemas), 1 (1 oedema), 2 (with 2 oedemas), and 3 (multiple oedemas localized in different regions).
f Total daily clinical score.
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calves 1 week after the infection. This lesion started with a
reddening around the coronary band at 5 days post-
infection (Fig. 3A), followed by an aggravation of the
inﬂammation and the addition of a localized oedema in the
coronet and pastern region at 8–9 days post-infection
(Fig. 3B–D). No one of the calves showed lameness or
difﬁculties in standing up, but the presence of a rubber
carpet was probably reducing the pain during the contact
of the feet on the ground.
A total daily clinical score was calculated for each
animal and it allowed appreciating the progression of the
disease (Table 1). The calves had few or unapparent clinical
signs the ﬁrst 3 days P.I., while starting from the 4th day,
the infection became clinically manifest. Since day 7 P.I.,
the severity of the disease enhancedwith the development
of multiple clinical signs: ocular discharge and conjuncti-
vitis, ulcers in the oral mucosa, lesions in the coronet and
pastern region and submandibular oedema (Table 1). In
addition, a very good correlation was observed between
the two calves for daily total score and total score by group
of clinical signs (rs = 0.86 and 1, respectively; P < 0.0001)
indicating a highly similar clinical pattern in the two
calves.
The development of viraemia and the seroconversion
of the inoculated calves represent evidences of the
occurred infection (Fig. 1B and C). BTV RNAwas ampliﬁed
in every EDTA–blood samples starting from 24 h post-
infection. Since 4 day P.I., the Ct values progressively
decreased, showing a constant increment of the viral RNAload in the blood of the two calves (Fig. 1B and C). The
quantiﬁcation of the BTV genome in the blood of the two
calves, allowed us to follow the dynamic of the viraemia.
The early detection of the viral RNA in the blood after 24 h
post-infection was probably due to the intravenous
injection of the virus. The temporary reduction of the
viral RNA load in the blood stream until the third day P.I.,
was probably to refer to the distribution of the virus to the
sites of primary and secondary replication, such as lymph
nodes, and spleen. Lymphoid organs are important sides
of viral replication in sheep and cattle (MacLachlan et al.,
1990). The subsequent increase of the viraemia 4 days P.I.,
was probably to refer to the transit of the virus from the
sites of massive replication to the blood stream. In the
literature for other BTV serotypes, it is reported that in
cattle the release of BTV from the spleen is followed by
high titer viraemia which persists for several weeks post-
infection (MacLachlan et al., 1990). After 14 days P.I., the
virus was detected by RT-qPCR in the spleen and the
tongue of both animals, while the tested lymph nodes
were negative (data not shown). These results are
probably explained by the fugacity of the viral replication
in the lymph nodes during the earliest phase of the
infection, and by the longer persistence of the virus in the
spleen. Similar ﬁndings were previously observed in
intravenously infected calves (MacLachlan et al., 1990,
2008).
The development of clinical signs in cattle infected
with BTV-8 is atypical because the disease in this animal
host ismore commonly undetectable. Before the outbreak
Fig. 3. After 5–6 days post-infection, we observed reddening of the coronary band (A), followed by reddening and oedema in the coronet and pastern region
at 8–9 days post-infection (B)–(D).
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rare clinicalmanifestations in cattle could be explained by
a hypersensitivity reaction and to the development of IgE-
speciﬁc antibody to BTV (Anderson et al., 1985). At present
no evidences of the involvement of an immunopatholo-
gical reaction in the development of the lesions showedby
cattle infected with BTV-8, have been documented. The
mechanisms explaining the severity of the lesions
produced by BTV-8 in cattle have to be investigated. In
particular, increased host susceptibility and higher
virulence of BTV-8 are the factors to be elucidated. The
availability of a model to characterize bluetongue disease
in cattle will be crucial for future investigations. The
experimental protocol presented in this study success-
fully reproduced the lesions observed in naturally
infected cattle and conﬁrmed the severity of the clinical
signs induced by BTV-8 in northern Europe.
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